Global Hemp Group Announces Jeff Nagel as Product Manufacturing Advisor
Global Hemp Group Announces Jeff Nagel as Product Manufacturing Advisor
Vancouver, British Columbia--(Newsfile Corp. - March 30, 2023) - GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) ("GHG" or the "Company") is pleased to announce that Jeff Nagel has joined the Company's Advisory Board as its Product Manufacturing Advisor.
不列颠哥伦比亚省温哥华--(Newsfile Corp.-2023年3月30日)-GLOBAL HEMP GROU(CSE:GHG)(场外交易链接:GBHPF)(FSE:GHG)(“GHG” 或 “公司”)欣然宣布,杰夫·纳格尔已加入公司的顾问委员会,担任其产品制造顾问。
Mr. Nagel is a veteran in the natural biologics drug discovery and manufacturing space, with more than 15 years' experience in the industry. He brings with him a wealth of knowledge and expertise that will be invaluable to Global Hemp Group Inc. both as an advisor to the R&D Division in their ongoing development of various hemp-based products and technologies, as well assisting Management in their continuing discussions with various manufacturers and distributors in the sublicensing of its exclusive license of Patents and Intellectual Property acquired from Apollon Formularies, plc ("Apollon") earlier this year.
纳格尔先生是天然生物制剂药物发现和制造领域的资深人士,在该行业拥有超过15年的经验。他带来了丰富的知识和专业知识,这对Global Hemp Group Inc.来说将是无价之宝,他既是研发部持续开发各种大麻类产品和技术的顾问,也是协助管理层继续与多家制造商和分销商讨论今年早些时候从Apollon Formularies, plc(“Apollon”)获得的专利和知识产权独家许可的再许可。
Jeff is currently Vice-President and Director of Medical Product Development at Apollon Formularies plc and was responsible for the production and manufacturing of all of the Apollon products demonstrated to be successful in killing breast and prostate cancer cells in Apollon's preclinical independent testing at BIOENSIS laboratories and currently sold by physician prescription in Jamaica. He was also responsible for manufacturing all of the natural biologics based medical products for the cancer clinical trials.
杰夫目前是Apollon Formularies plc的副总裁兼医疗产品开发总监,负责生产和制造所有在Apollon在BIOENSIS实验室进行的临床前独立测试中被证明可以成功杀死乳腺癌和前列腺癌细胞的阿波罗产品,目前在牙买加通过医生处方出售。他还负责为癌症临床试验生产所有基于天然生物制剂的医疗产品。
In the event that GHG exercises its option to acquire the entirety of the Apollon assets per the binding Letter of Intent executed between the Parties (for further detail on the transaction, see the news release of January 11, 2023 and March 20, 2023), the Company will look to bring on Mr. Nagel as its Vice-President and Director of Global Manufacturing ("DGM"). As VP and DGM Jeff's role will be to oversee the Company's global manufacturing operations of the Apollon products, including product development, quality control, and supply chain management, and work closely with the Company's executive team to develop and execute manufacturing strategies that align with the company's overall goals and objectives.
如果温室气体根据双方签署的具有约束力的意向书行使收购阿波罗全部资产的选择权(有关交易的更多细节,请参阅2023年1月11日和2023年3月20日的新闻稿),该公司将寻求聘请纳格尔先生担任其副总裁兼全球制造总监(“DGM”)。作为副总裁兼副总经理,杰夫的职责将是监督公司阿波罗产品的全球制造业务,包括产品开发、质量控制和供应链管理,并与公司的执行团队密切合作,制定和执行与公司总体目标和宗旨相一致的制造战略。
"I am excited to join the team at Global Hemp Group, Inc. and contribute to the growth and success of the company," said Nagel. "I believe that the recent exclusive intellectual property licenses procured from Apollon opens the door for the creation of some amazing and innovative new products in the natural biologics space!"
纳格尔说:“我很高兴能加入Global Hemp Group, Inc.的团队,为公司的发展和成功做出贡献。”“我相信,最近从阿波罗获得的独家知识产权许可为在天然生物制剂领域创造一些神奇而创新的新产品打开了大门!”
"Jeff's extensive experience and expertise in manufacturing and product formulation will greatly assist the Company as it talks to manufacturers and distributors about sublicensing and monetizing GHG's exclusive licenses from Apollon" said Stephen Barnhill, Jr, Interim CEO of Global Hemp Group, Inc. "We are thrilled to have him on board and look forward to working with him to take this segment of our business to the next level."
Global Hemp Group, Inc.临时首席执行官Stephen Barnhill表示:“杰夫在制造和产品配方方面的丰富经验和专业知识将极大地帮助公司与制造商和分销商讨论从阿波罗获得的温室气体独家许可和货币化问题,” Global Hemp Group, Inc.临时首席执行官Stephen Barnhill说,“我们很高兴有他加入,并期待与他合作,将我们的这一部分业务提升到一个新的水平。”
About Global Hemp Group Inc.
关于全球大麻集团公司
Global Hemp Group Inc. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) is focused on developing and promoting hemp-based products that are sustainable, environmentally friendly, and have a positive impact on society. To further support and innovate, GHG has established a R&D Division to actively pursue the development of Intellectual Property that can be patented for implementation at its projects and beyond. The Division is led by Prof. Víctor M. Castaño, Ph.D. whose career has focused in the areas of applied science and technology. The R&D team is initially focused on development of Environmentally Friendly Construction Materials, Nanofertilizers and Enhanced Cannabinoid Extraction from Hemp.
Global Hemp Group Inc.(CSE:GHG)(场外交易链接:GBHPF)(FSE:GHG)专注于开发和推广可持续、环保且对社会产生积极影响的大麻类产品。为了进一步支持和创新,GHG 成立了研发部门,积极开发可申请专利的知识产权,以便在其项目及其他领域实施。该司由维克托·卡斯塔诺教授领导,他是博士,其职业生涯集中在应用科学和技术领域。研发团队最初专注于开发环保建筑材料、纳米肥料和从大麻中提取增强的大麻素。
Subscribe to the GHG YouTube Channel:
订阅 GHG YouTube 频道:
Like us on Facebook:
在脸书上点赞我们:
Follow us on Instagram:
在 Instagram 上关注我们:
Follow us on Twitter:
在推特上关注我们:
Connect with us on LinkedIn:
在 LinkedIn 上联系我们:
For Further Information Contact Global Hemp Group
欲了解更多信息,请联系全球大麻集团
Investor Relations
投资者关系
Tel: 778-726-2900
电话:778-726-2900
info@globalhempgroup.com
info@globalhempgroup.com
Cautionary Note Regarding Forward Looking Statements
关于前瞻性陈述的警示说明
Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of Global Hemp Group Inc., including, but not limited to, the impact of general economic conditions, industry conditions, volatility of commodity prices, currency fluctuations, dependence upon regulatory approvals, the availability of future financing and exploration risk, and the legality of cannabis and hemp. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of Page 2 of 2 preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Except as required by law, Global Hemp Group Inc. disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.
本新闻稿中列出的某些信息可能包含前瞻性陈述,涉及重大的已知和未知风险和不确定性。这些前瞻性陈述受到许多风险和不确定性的影响,其中某些风险和不确定性是Global Hemp Group Inc.无法控制的,包括但不限于总体经济状况、行业状况、大宗商品价格波动、货币波动、对监管批准的依赖、未来融资和勘探风险的可用性以及大麻和大麻的合法性的影响。提醒读者,在准备此类信息时使用的假设虽然在编写第2页时被认为是合理的,但可能被证明是不准确的,因此,不应过分依赖前瞻性陈述。除非法律要求,否则Global Hemp Group Inc.否认任何意图,也没有义务更新或修改任何前瞻性陈述以反映实际结果,无论是由于新信息、未来事件、假设变化、影响此类前瞻性陈述的因素变化还是其他原因造成的。
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
CSE 尚未审查本新闻稿的充分性或准确性,也不承担任何责任。
To view the source version of this press release, please visit
要查看本新闻稿的源版本,请访问